API Nanotronics, Corp., a leading supplier of electronic components and nanotechnology research and development to the defense and communications sectors, today announced record orders of more than $9.0 million for the third quarter ended February 29, 2008.
Arrowhead Research Corporation announced today that its majority owned subsidiary, Calando Pharmaceuticals, a leading siRNA therapeutics company, submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration to initiate a Phase I clinical trial using their lead anti-cancer compound, CALAA-01.
Researchers at TopChim, a developer of materials and technology solutions for the paper industry, have integrated the Zetasizer Nano particle characterization system from Malvern Instruments into the company?s nanoscience development program.
Any windows can be self-cleaning, according to SCF Technologies. It has become the first company to develop an aftermarket window coating that uses the sun's energy to break down dust and grime, saving time and helping protect the environment
Tronics Microsystems SA, a leading global manufacturer of custom MEMS components for demanding applications, and IMEC, representing Europractice IC Service, announced today their collaboration to enable Europractice IC Service to add MEMS to its Multi-Project Wafer programs.
Altair Nanotechnologies Inc., a leading provider of advanced nanomaterials technology for use in energy, pharmaceutical, life sciences and industrial applications, today reported financial results for the fiscal year ended December 31, 2007.
Unidym, Inc., a majority-owned subsidiary of Arrowhead Research Corporation, announced today that it has entered into a joint development agreement with Nippon Kayaku, to integrate Unidym's printable transparent electrodes into Nippon Kayaku's thin film solar cells. Nippon Kayaku Co. is a diversified Japanese chemical company with over $1.4B in 2007 sales that is bringing its global development and manufacturing capabilities to the rapidly developing thin film solar cell market.
Altogen Biosystems announced launch of new contract research services. Altogen Custom Services focus on providing specialized biotechnology and pharmaceutical services, including RNA Interference (RNAi) services, generation of stably-expressing cell lines, assay development, screening and transfection services. In particular, the company will draw upon their unique experience with over hundred cancer cell lines and expertise in polymer and nanoparticle-based gene delivery technologies.
Nanogen, Inc., developer of innovative, high-quality diagnostic products, will host a conference call on Thursday, March 13, 2008 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to discuss 2007 fourth quarter and full year financial results.
I-Flow Corporation is leading and helping to define a rapidly emerging trend of using silver as an antimicrobial agent to help reduce infections with its ON-Q PainBuster with ON-Q SilverSoaker Antimicrobial Catheter combination.
Together with its four consortium partners, KINAXO Biotechnologies GmbH has reached the final round of 'BioPharma - The Strategy Competition for Medicine of the Future,' an initiative of the German federal government.
Liquidia Technologies, a nanotechnology company focused on development of engineered particle-based therapeutics and featured optical films, announced today the appointment of Seth A. Rudnick, M.D. as Chairman of its Board of Directors. Dr. Rudnick has been an adjunct clinical professor of medicine at The University of North Carolina-Chapel Hill and is a partner at Canaan Partners, a global venture capital firm.
CVD Equipment Corporation completed the acquisition of a new 13,000 square foot building to facilitate the scale up and commercialization of new products for the Nano, Solar, Energy and Semiconductor fields.